National Alliance of Sickle Cell Centers Consensus Recommendations on Sickle Cell Disease Health Maintenance

People with SCD require coordinated and consistent care starting soon after birth in an SCD center and throughout their lives; SCD is a chronic condition with a highly heterogenous phenotype necessitating lifelong care through an SCD center in collaboration with clinicians in multiple areas of medicine including primary care. Future work should prioritize the management of timing of initiation and precision use of disease-modifying therapies, infection management and prevention, and discussion on transformative therapies.

Authors

Institutions

Publication Details

Journal
JAMA Network Open
Published
2025-11-13
DOI
https://doi.org/10.1001/jamanetworkopen.2025.43421
Citations
4
Primary Topic
Hemoglobinopathies and Related Disorders
Type
article
Field-Weighted Citation Impact
6.50
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

National Alliance of Sickle Cell Centers Consensus Recommendations on Sickle Cell Disease Health Maintenance

Deepa Manwani, Monica L. Hulbert, Parul Rai, Amma Owusu‐Ansah et al.
4 citations
JAMA Network Open
Hemoglobinopathies and Related Disorders
6.50
article

National Alliance of Sickle Cell Centers Consensus Recommendations on Sickle Cell Disease Health Maintenance

Deepa Manwani, Monica L. Hulbert, Parul Rai, Amma Owusu‐Ansah, Ravi Talati, Angeli Rampersad, Seethal A. Jacob, Francis Coyne, Patrick McGann, Julie Kanter, Andrew R. W. O’Brien, Sophie Lanzkron, Neha Bhasin, Anthony Villella, Vishwas Sakhalkar, Crawford Strunk, R Eric Miller, Melissa Frei‐Jones, Sana Saif-Ur-Rehman
article en
4 citations

Abstract

People with SCD require coordinated and consistent care starting soon after birth in an SCD center and throughout their lives; SCD is a chronic condition with a highly heterogenous phenotype necessitating lifelong care through an SCD center in collaboration with clinicians in multiple areas of medicine including primary care. Future work should prioritize the management of timing of initiation and precision use of disease-modifying therapies, infection management and prevention, and discussion on transformative therapies.

JAMA Network OpenVol. 8(11)
Boston Children's Hospital (US), St. Jude Children's Research Hospital (US), Nationwide Children's Hospital (US), Rhode Island Department of Health (US), Thomas Jefferson University (US), The University of Texas at San Antonio Health Science Center (US), Washington University in St. Louis (US), Augusta University (US), Brown University (US), Riley Hospital for Children (US), University of Rochester Medical Center (US), University of Alabama at Birmingham (US), Cleveland Clinic Lerner College of Medicine (US), Augusta University Health (US), Center for Cancer and Blood Disorders (US), Innovative Clinical Research (US), UCSF Benioff Children's Hospital (US), Boston Children's Museum (US), Rainbow Babies & Children's Hospital (US), Indiana University School of Medicine, Indiana University – Purdue University Indianapolis (US)
Openalex Percentile: Top 3%
Hemoglobinopathies and Related Disorders
6.50
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.